The Your
Sep 11, 2026
HyperLocal Loop
The Your

Close to home. Always in the loop.

Flu Season 2025‑2026: Natural Remedies, mRNA Vaccine Debate, and the Risks of Common Antivirals

By OBBM Network Editorial Staff

Derived from an episode of Dr. Ardis Show.

What if the flu shot you’re being urged to take this winter hasn’t been proven safe for the long term? Dr. Bryan Ardis dives into the data, the politics, and the practical options for anyone trying to stay healthy during flu season.

Understanding Flu Season and Who Is Most at Risk

Dr. Ardis begins by listing the classic flu symptoms—sore throat, cough, fever, body aches, fatigue, and headaches—while noting they overlap with COVID‑19 and the common cold. He points out that the CDC identifies children under five, adults over 65, pregnant people, and those with chronic conditions such as asthma or COPD as especially vulnerable.

He also challenges the commonly cited mortality figures. While the Cleveland Clinic reports “between 20,000 and 50,000” annual flu deaths in the United States, Dr. Ardis calls this a “flat‑out lie,” arguing that the CDC’s weekly morbidity and mortality reports have not supported those numbers in recent years.

The Controversial Approval of an mRNA Flu Vaccine

In February 2025, the FDA approved Moderna’s mRNA flu vaccine for adults 50‑65 and those 65 and older, despite earlier rejecting the application for insufficient trial data. Dr. Ardis highlights that nine members of the FDA’s Independent Vaccine Advisory Panel—who had never seen long‑term studies of the shot—voted unanimously to approve it.

He alleges a rapid shift in the FDA’s stance, suggesting a possible “bribe” after the agency initially declined review. “Two weeks later, they approve it,” Dr. Ardis says, questioning the integrity of the process.

“The panel endorsed the drugmaker request for traditional approval for the vaccine in adults,” he notes, emphasizing that all nine advisors have financial ties to pharmaceutical companies, including Merck, which produces many vaccines.

Antiviral Drugs: Are Tamiflu and Others Safe?

Turning to prescription options, Dr. Ardis reviews Tamiflu, an antiviral that blocks influenza A and B viruses. He cites side‑effect rates from Drugs.com, noting that 17% of users experience headaches and that more severe reactions—including insomnia, hallucinations, and even suicidal behavior—affect roughly one in ten patients.

He also warns that “one in 10 people get the flu from Tamiflu,” a claim based on reported influenza‑like illness among users. The drug’s potential to trigger asthma attacks, sinusitis, pneumonia, and even herpes outbreaks is highlighted as a significant concern for patients seeking relief.

CDC Recommendations vs. Independent Findings

The CDC’s website still lists a yearly flu vaccine as the “first and most important” preventive measure for everyone six months and older. Dr. Ardis juxtaposes this with a recent Cleveland Clinic pre‑print that found a 27% increase in flu cases among vaccinated healthcare workers, suggesting the vaccine may not be as protective as advertised.

He urges listeners to scrutinize official guidance, noting that the CDC’s own data on hospitalizations and deaths may be overstated. “The CDC says flu vaccines reduce the burden on the healthcare system,” Dr. Ardis says, “but new research suggests the opposite for some groups.”

Natural Strategies for a Healthier Flu Season

Beyond pharmaceuticals, Dr. Ardis recommends several natural approaches: maintaining adequate sleep, staying hydrated, consuming vitamin‑C‑rich foods, and using over‑the‑counter zinc lozenges at the first sign of symptoms. He stresses that these measures can bolster the immune system without the risks associated with vaccines or antivirals.

He also advises people with asthma or COPD to avoid the antiviral Relenza, which the FDA does not recommend for those conditions, and to discuss alternative treatments with their doctors.

Conclusion: Navigating Choices in a Complex Landscape

The flu season of 2025‑2026 arrives with a mix of new technology, longstanding medications, and a flood of public‑health messaging. Dr. Bryan Ardis’s analysis underscores the importance of looking beyond headlines, questioning rapid regulatory approvals, and considering both medical and natural options. As families decide how to protect themselves, a critical, informed approach may be the most effective defense against the flu.

The full episode of Dr. Ardis Show is available on OBBM Network TV.


Watch the full episode:

OBBM Network Editorial Staff

[email protected]

Editorial team behind OBBM Network — independent, hyper-local journalism syndicated through HyperLocalLoop and OBBM Network TV.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News

Trending

Community News

Quick Start Deal

Get Loop-Ready in One Move

A low-commitment monthly bundle that keeps your business in front of local audiences across HyperLocal Loop and the OBBM Network.

$350 Per Month
What's Included
  • DataPulse · 1,000 Matches Identify and retarget anonymous visitors to your site
  • Banner Ads Geo-targeted display placement across HyperLocal Loop
  • Video Ad Airs on your Local OBBM Channel
  • Business Advertorial A featured sponsored article telling your story
Questions about any of this? Ask Ben →
Get Started
Secure checkout · Cancel anytime
§ 04 · Choose Your Package

Three levels. Up to 60% off.

Every Patriot Package is priced at over 40% off standard AdRevv list rates — and the discount deepens as you scale, up to 60% off at the Enterprise tier.

Tier I · Local
The Patriot
For local & regional brands launching with the network.
List Price: $835/mo
$500/mo
★ Save $335 — 40% Off
Monthly Allotment
  • Audio: 10,000Podcast impressions
  • Video: 10,000Streaming TV impressions
  • Banners: 50,000HyperLocal Loop geo-targeted banner impressions
  • DataPulse: First 1,000visitor matches included
  • City or regional geo-targeting via AdServe
  • Real-time campaign reporting
Start The Patriot
Tier III · National
The Enterprise
For national brands ready to dominate the network.
List Price: $5,065/mo
$2026/mo
★ Save $3,039 — 60% Off
Monthly Allotment
  • Audio: 14,000Podcast impressions
  • Video: 10,000Streaming TV impressions
  • Banners: 100,000HyperLocal Loop geo-targeted impressions
  • DataPulse: 5,000visitor matches included
  • LeadEngine: 20,000actionable buyer-intent contacts
  • Host Endorsements: 9podcast host-read spots
  • National geo-targeting + dedicated campaign manager
  • Priority creative production support
★ Bonus Included
Free 1-Year Freedom Chamber Membership
Faith, Family & Freedom business community at freedomchamber.net.
Start Enterprise

Need a custom configuration? Build your own package →